REQUEST A DEMO
Total
USD $0.00
Search more companies

Aurigene Oncology Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Aurigene Oncology Limited Profile Updated: November 11, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Aurigene Discovery Technologies is a clinical stage biotech company. It is a wholly owned subsidiary of Dr. Reddy's Laboratories Ltd. The company focuses on precision oncology, oral immune checkpoint inhibitors, and the Th-17 pathway, with expertise in cancer and inflammatory disorders. Aurigene has delivered 16 small molecule and peptide drug candidates currently in clinical development and has out-licensed several compounds to pharma and biotech companies for global clinical development. The company has undertaken clinical POC studies for a few programs on its own.

Headquarters
39/49(P)Kiadb Industrial Area Electronics City Phase Ii Bangalore Ka Bangalore In-Ka In 560100
Bangalore; Karnataka; Postal Code: 560100

Contact Details: Purchase the Aurigene Oncology Limited report to view the information.

Basic Information
Total Employees:
Purchase the Aurigene Oncology Limited report to view the information.
Outstanding Shares:
Purchase the Aurigene Oncology Limited report to view the information.
Registered Capital:
Purchase the Aurigene Oncology Limited report to view the information.
Financial Auditors:
Purchase the Aurigene Oncology Limited report to view the information.
Incorporation Date:
August 10, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Aurigene Pharmaceutical Services Limited
100%
Company Performance
Financial values in the chart are available after Aurigene Oncology Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
38.88%
Total operating revenue
36.08%
Operating profit (EBIT)
109.19%
EBITDA
98.4%
Net Profit (Loss) for the Period
107.79%
Total assets
-0.06%
Total equity
22.78%
Operating Profit Margin (ROS)
8.64%
Net Profit Margin
6.31%
Return on Equity (ROE)
7.77%
Quick Ratio
2%
Cash Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?